O. Burgy (Dijon, France), C. Masterson (Galway (Co Galway), Ireland)
Partial apoptosis of epithelial cells in fibrotic lungs.
E. Vasarmidi (Paris, France), A. Guyard (Paris, France), N. Pote (Paris, France), P. Mordant (Paris, France), A. Cazes (Paris, France), B. Crestani (Paris, France), A. Mailleux (Paris, France)
|   |
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics
M. Gerckens (Munich, Germany), K. Schorpp (Neuherberg, Germany), F. Pelizza (Glasgow, United Kingdom), M. Wögrath (Munich, Germany), K. Reichau (Neuherberg, Germany), H. Ma (Neuherberg, Germany), A. Dworsky (Munich, Germany), A. Sengupta (Munich, Germany), M. Stoleriu (Munich, Germany), K. Heinzelmann (Munich, Germany), J. Merl-Pham (Neuherberg, Germany), M. Irmler (Neuherberg, Germany), H. Alsafadi (Lund, Sweden), E. Trenkenschuh (Munich, Germany), L. Sarnova (Prague, Czech Republic), M. Jirouskova (Prague, Czech Republic), W. Frieß (Munich, Germany), S. Hauck (Neuherberg, Germany), J. Beckers (Neuherberg, Germany), N. Kneidinger (Munich, Germany), J. Behr (Munich, Germany), A. Hilgendorff (Munich, Germany), K. Hadian (Neuherberg, Germany), M. Lindner (Salzburg, Austria), M. Königshoff (Pittsburgh, United States), O. Eickelberg (Pittsburgh, United States), M. Gregor (Prague, Czech Republic), O. Plettenburg (Neuherberg, Germany), A. Yildirim (Munich, Germany), G. Burgstaller (Munich, Germany)
| |
Next generation of gene-editing technologies for respiratory research and medicine
S. Cuevas Ocaña (Nottingham, United Kingdom), A. Serna Valverde (Nottingham, United Kingdom), L. Reed (Nottingham, United Kingdom), N. Hannan (Nottingham, United Kingdom)
| |
Role of cellular adhesion molecules in the presence of interstitial lung disease in patients with autoimmune diseases
V. Pulito-Cueto (Santander, Spain), S. Remuzgo-Martinez (Santander, Spain), F. Genre (Santander, Spain), B. Atienza-Mateo (Santander, Spain), V. Portilla (Santander, Spain), V. Mora-Cuesta (Santander, Spain), D. Iturbe-Fernández (Santander, Spain), L. Lera-Gómez (Santander, Spain), D. Prieto-Pena (Santander, Spain), R. Blanco (Santander, Spain), A. Corrales (Santander, Spain), O. Gualillo (Santiago de Compostela, Spain), J. Cifrián (Santander, Spain), R. López-Mejías (Santander, Spain), M. González-Gay (Santander, Spain)
| |
Spatial transcriptome analysis at single-cell resolution for understanding IPF pathogenesis
N. Watanabe (Tokyo, Japan), Y. Fujita (Tokyo, Japan), T. Ishiguro (Tokyo, Japan), N. Takahashi (Tokyo, Japan), Y. Shimizu (Tokyo, Japan), N. Takayanagi (Tokyo, Japan), Y. Kawabata (Tokyo, Japan), J. Araya (Tokyo, Japan), Y. Yamamoto (Tokyo, Japan), K. Kuwano (Tokyo, Japan)
| |
Computational drug repositioning and wet-lab validation approach identifies polo-like kinase inhibitors as potential therapeutics for pulmonary fibrosis
T. Imakura (Tokushima, Japan), S. Sato (Tokushima, Japan), K. Koyama (Tokushima, Japan), H. Ogawa (Tokushima, Japan), T. Niimura (Tokushima, Japan), K. Murakami (Tokushima, Japan), Y. Yamashita (Tokushima, Japan), K. Haji (Tokushima, Japan), N. Naito (Tokushima, Japan), K. Kagawa (Tokushima, Japan), H. Kawano (Tokushima, Japan), Y. Zamami (Tokushima, Japan), K. Ishizawa (Tokushima, Japan), Y. Nishioka (Tokushima, Japan)
| |
Identification of different lung immune-phenotypes in Idiopathic pulmonary fibrosis (IPF)
T. Cruz (Barcelona, Spain), N. Mendoza (Barcelona, Spain), S. Casas (Barcelona, Spain), F. Hernandez (Barcelona, Spain), N. Albacar (Barcelona, Spain), J. Sembrant (Pittsburgh, United States), M. Rojas (Ohio, United States), A. Agusti (BARCELONA, Spain), J. Sellares (BARCELONA, Spain), R. Faner (BARCELONA, Spain)
| |
Endothelial to mesenchymal transition (EndMT) and arterial remodelling in IPF patients
M. Eapen (Launceston (TAS), Australia), A. Gaikwad (Launceston (TAS), Australia), P. Bhattarai (Launceston (TAS), Australia), S. Dey (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), J. Jaffar (Melbourne (Vic), Australia), G. Westall (Melbourne (Vic), Australia), G. Singhera (Vancouver (BC), Canada), T. Hackett (Vancouver (BC), Canada), W. Lu (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia)
| |
Late Breaking Abstract - Single cell RNA sequencing suggests Gai2 is associated with ILD in pigeon fanciers
D. Somma (Glasgow, United Kingdom), M. Spears (Perth, United Kingdom), L. Wain (Leicester, United Kingdom), R. Allen (Leicester, United Kingdom), O. Leavy (Leicester, United Kingdom), B. Gooptu (Leicester, United Kingdom), S. Bourke (Newcastle, United Kingdom), M. Kurowska-Stolarska (Glasgow, United Kingdom), C. Mcsharry (Glasgow, United Kingdom)
| |
Endothelin-1 for the differential diagnosis between interstitial lung disease associated with autoimmune diseases and idiopathic pulmonary fibrosis
S. REMUZGO-MARTÍNEZ (Santander, Spain), B. Atienza-Mateo (Santander, Spain), V. Pulito-Cueto (Santander, Spain), F. Genre (Santander, Spain), V. Mora-Cuesta (Santander, Spain), D. Iturbe-Fernández (Santander, Spain), V. Portilla (Santander, Spain), O. Gualillo (Santiago de Compostela, Spain), A. Corrales (Santander, Spain), S. Castañeda (Madrid, Spain), R. López-Mejías (Santander, Spain), J. Cifrián (Santander, Spain), M. González-Gay (Johannesburg, South Africa)
| |
Involvement of microRNAs in the development of the bleomycin-induced pulmonary fibrosis model
V. Pitozzi (Parma (PR), Italy), P. Caruso (Parma (PR), Italy), M. Pittelli (Parma (PR), Italy), S. Pontis (Parma (PR), Italy), M. Bonatti (Parma (PR), Italy), F. Ruscitti (Parma (PR), Italy), M. Civelli (Parma (PR), Italy), M. Trevisani (Parma (PR), Italy)
| |
Differentially expressed genes in Diffuse Alveolar Damage (DAD) patterns of COVID-19.
N. de Souza Xavier Costa (São Paulo, Brazil), J. Sirino Monteiro (São Paulo, Brazil), J. Erjefält (Lund, Sweden), J. Jönsson (Lund, Sweden), O. Cozzolino (Lund, Sweden), K. Dantas (São Paulo, Brazil), C. Clausson (Lund, Sweden), P. Siddhuraj (Lund, Sweden), C. Lindö (Lund, Sweden), S. Ferreira Spina Lombardi (São Paulo, Brazil), A. Mendroni Júnior (São Paulo, Brazil), L. Antonangelo (São Paulo, Brazil), C. Silvério Faria (São Paulo, Brazil), A. Nunes Duarte Neto (São Paulo, Brazil), R. Almeida Monteiro (São Paulo, Brazil), J. Rebello Pinho (São Paulo, Brazil), M. Soares Gomes-Gouvêa (São Paulo, Brazil), R. Verciano Pereira (São Paulo, Brazil), E. Pierre De Oliveira (São Paulo, Brazil), J. Theodoro Filho (São Paulo, Brazil), C. Sanden (Lund, Sweden), J. Orengo (Tarrytown, United States), M. Sleeman (Tarrytown, United States), L. Ferraz Da Silva (São Paulo, Brazil), P. Nascimento Saldiva (São Paulo, Brazil), M. Dolhnikoff (São Paulo, Brazil), T. Mauad (São Paulo, Brazil), J. Setubal (São Paulo, Brazil)
| |
Identification of highly immunogenic epitopes in the SARS-CoV-2 Spike protein to produce monoclonal antibodies
L. Fernandez Barat (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Farriol (Barcelona, Spain), E. Porta (Barcelona, Spain), À. López-Gavin (Barcelona, Spain), A. Motos (Barcelona, Spain), R. Aguilar (Barcelona, Spain), M. Vidal (Barcelona, Spain), A. Jiménez (Barcelona, Spain), R. Cabrera (Barcelona, Spain), N. Vázquez (Barcelona, Spain), E. Barbeta (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Palomeque (Barcelona, Spain), G. Moncunill (Barcelona, Spain), M. Lozano (Barcelona, Spain), A. Garcia-Basteiro (Barcelona, Spain), C. Dobaño (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Metabolomic spittle analysis of post COVID-19 patients
L. Machado (Botucatu, Brazil), R. Prudente (Botucatu, Brazil), E. Franco (Botucatu, Brazil), M. Gatto (Botucatu, Brazil), G. Mota (Botucatu, Brazil), L. Pagan (Botucatu, Brazil), L. Brizola (Botucatu, Brazil), M. Dos Santos (Botucatu, Brazil), T. Cunha (Uberlândia, Brazil), R. Sabino-Silva (Uberlândia, Brazil), L. Filho (Uberlândia, Brazil), M. Martins (Uberlândia, Brazil), P. Santos (Uberlândia, Brazil), L. Maia (Uberlândia, Brazil), A. Albuquerque (São Paulo , Brazil), E. Machado (São Paulo, Brazil), B. Baldi (São Paulo, Brazil), S. Tanni (Botucatu, Brazil)
| |
Elevated plasma levels of CXCL16 in severe COVID19 patients.
S. Smieszek (Washington, United States)
| |
TNFTNFRSF1A, and TNFRSF1B variants affect TNFR1 and TNFR2 levels in patients with severe COVID-19
I. Fricke-Galindo (Mexico City, Mexico), I. Buendía-Roldán (Mexico City, Mexico), L. Chávez-Galán (Mexico City, Mexico), G. Pérez-Rubio (Mexico City, Mexico), A. Ruiz (Mexico City, Mexico), Y. Palacios-Rodríguez (Mexico City, Mexico), R. Hernández-Zenteno (Mexico City, Mexico), R. Falfán-Valencia (Mexico City, Mexico)
| |
Proteomic determinants of disease, mortality and sequelae in COVID-19 patients requiring invasive mechanical ventilation
M. Molinero García (Lleida, Spain), S. Gómez (Lleida, Spain), I. Benítez (Lleida, Spain), J. Vengoechea (Lleida, Spain), J. González (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), M. García-Hidalgo (Lleida, Spain), M. Pérez-Pons (Lleida, Spain), G. Torres (Lleida, Spain), J. Caballero (Lleida, Spain), C. Barberà (Lleida, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. García-Gasulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), Ó. Peñuelas (Madrid, Spain), J. Riera (Barcelona, Spain), J. Bermejo-Martín (Salamanca, Spain), A. Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain)
| |
Molecular genetic markers associated with course of severe COVID-19 pneumonia. Different pathways study.
N. Gorovenko (Kyiv, Ukraine), M. Ostrovskyy (Ivano-Frankivsk, Ukraine), Z. Rossokha (Kyiv, Ukraine), L. Fishchuk (Kyiv, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine), V. Vershyhora (Kyiv, Ukraine), O. Dubitskaya (Kyiv, Ukraine), N. Medvedieva (Kyiv, Ukraine), O. Popova (Kyiv, Ukraine)
| |
The dysregulation of the monocyte-dendritic cell interplay is associated with in-hospital mortality in COVID-19 pneumonia
M. Bocchino (naples, Italy), S. Sale (naples, Italy), C. Nicastro (naples, Italy), l. capitelli (naples, Italy), C. Lombardi (naples, Italy), A. Sanduzzi Zamparelli (naples, Italy), L. Atripaldi (naples, Italy), D. Galati (naples, Italy)
| |
Development of a Deep Learning Immune Cell Abundance Model Predict 28-Day Survival in Patients with Sepsis
Y. Gu (Guangzhou City, China), X. Liu (Guangzhou City, China), X. Li (Guangzhou City, China), N. Zhang (Guangzhou City, China), H. Li (Guangzhou City, China), W. Qin (Guangzhou City, China), T. Yu (Guangzhou City, China), L. Li (Guangzhou City, China)
| |